Bromoacetamido-PEG2-C2-acid Catalog No.:M32138-C Smiles: [2H]C(O)(C([2H])([2H])NCC)C([2H])([2H])OC1=CC=C(C=C1C(C)=O)NC(=O)CCC

Smiles: [2H]C(O)(C([2H])([2H])NCC)C([2H])([2H])OC1=CC=C(C=C1C(C)=O)NC(=O)CCC

Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function

H3O4P/c1-11(5-3-7-16)18-14-10-13(19-2)9-12-6-4-8-17-15(12)14

Gimeracil enhances the antitumor activity of fluoropyrimidines by competitively and reversibly inhibiting the enzyme dihydropyrimidine dehydrogenase causing decreased degradation of the fluoropyrimidines

Lometrexol hydrate (DDATHF hydrate) binds tightly to GART

Bromoacetamido-PEG2-C2-acid Catalog No.:M32138-C Smiles: [2H]C(O)(C([2H])([2H])NCC)C([2H])([2H])OC1=CC=C(C=C1C(C)=O)NC(=O)CCCBromoacetamido PEG2 C2 acid is a PEG based PROTAC linker that can be used in the synthesis of PROTACs. Product information CAS Number: 1415800 44 0 Molecular Weight: 298. 13 Formula: C9H16BrNO5 Chemical Name: 3 {2 [2 (2 bromoacetamido)ethoxy]ethoxy}propanoic acid Smiles: OC(=O)CCOCCOCCNC(=O)CBr InChiKey: PIANHFIJCGRNCU UHFFFAOYSA N InChi: InChI=1S C9H16BrNO5 c10 7 8(12)11 2 4 16 6 5 15 3 1 9(13)14 h1 7H2,(H,11,12)(H,13,14) Technical Data Appearance: